| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anesthesiology, Shimane Medical University, Izumo, Japan.
Address correspondence to: Dr. Katsushi Doi, Department of Anesthesiology, Shimane Medical University, 89-1 Enya-cho, Izumo, 693-8501, Japan. Phone: +81-853-20-2295; Fax: +81-853-20-2292; E-mail: kdoi{at}shimane-med.ac.jp
| Abstract |
|---|
|
|
|---|
Clinical features: A 14-yr-old girl with JBD was scheduled for resection of a gingival tumour and an infected sinus in the sacral area. Her preanesthetic examination revealed extreme muscle atrophy and dementia. Grand mal, myoclonic seizures, and upper airway obstruction were frequent. Following iv induction with thiamylal, anesthesia was maintained with sevoflurane, N2O and O2. Her trachea was intubated without using muscle relaxants. Muscle relaxants were not used during the operation. Apart from an intractable hypothermia, the intraoperative course was uneventful. The emergence of anesthesia was smooth, except for persisting seizures.
Conclusion: General anesthesia using thiamylal and sevoflurane provided satisfactory conditions during operation in a patient with JBD. Intraoperative hypothermia required particular attention.
| Introduction |
|---|
|
|
|---|
| Case report |
|---|
|
|
|---|
The patient took valproic acid 760 mg, clonazepam 0.1 mg, and diazepam 2 mg orally until two hours before the operation. After atropine 0.25 mg iv, anesthesia was induced with thiamylal 100 mg iv, followed by sevoflurane via facemask. Her trachea was intubated without using muscle relaxants. A reinforced 6.0-mm endotracheal cuffed tube was used in this case. Anesthesia was maintained with 66% nitrous oxide and 13% sevoflurane in oxygen. Muscle relaxants were not used during the operation. She was ventilated mechanically during surgery. End-tidal concentrations of carbon dioxide, nitrous oxide and sevoflurane were monitored by a Datex Capnomac Ultima (Helsinki, Finland). Body temperature was monitored with a rectal thermometer. Her baseline temperature was 36.5°C at the start of the operation. Although intraoperative hemodynamics remained stable, the patient developed hypothermia after being placed in the prone position. Two hours after the start of the operation, her rectal temperature dropped to 34.5°C. The hypothermia persisted throughout surgery despite attempts at rewarming with a humidifier, fluid warmer and circulating-water-mattress. After surgery, we used a forced-air warmer for 90 min. She emerged from anesthesia smoothly after normalization of body temperature. Duration of surgery and anesthesia was five hours and 25 min and eight hours and 15 min, respectively. Although severe myoclonus was observed, her respiratory and circulatory conditions remained stable. Myoclonus was controlled using diazepam 2 mg intravenously. The postoperative course was otherwise uneventful, and neurological symptoms were not exacerbated after the operation.
| Discussion |
|---|
|
|
|---|
First, the use of muscle relaxants can be a problem, because muscle abnormality involves amyotrophy and myotony.5 We did not use muscle relaxants for endotracheal intubation to prevent any associated problems, including prolonged effect of the drugs. Moreover, sevoflurane can provide sufficient muscle relaxation to facilitate tracheal intubation6,7 and the surgical procedure did not require further muscle relaxation in this case. If a muscle relaxant had been required in this patient, a short-acting nondepolarizing muscle relaxant should be used and titrated carefully. Succinylcholine should be avoided because of possible hyperkalemia and malignant hyperthermia in patients with neuromuscular disorders.5
Second, the risk of exacerbating neurological symptoms was a consideration that oriented our choice of anesthetic agents. The patient had taken several types of anticonvulsants. The mechanisms of action of these anticonvulsants may involve drug-induced increases in the activity of inhibitory neurotransmitters such as GABA.8 We used titrated doses of thiamylal for induction, because thiamylal is known to share the same mechanism of action with these anticonvulsants. In addition, thiamylal has a rapid onset and short duration of action.9 Sevoflurane was selected because of its low blood gas partition coefficient and anticonvulsive action at low concentrations,6,10 an interesting characteristic in this patient. Although sevoflurane has been implicated in causing seizure-like activity,11,12 other inhalation anesthetics, including isoflurane, can also trigger spike wave activity in the electroencephalogram and convulsion.13 Interestingly, these inhalational anesthetics have also anticonvulsive action when used at a low concentration.
Third, in patients with complex abnormalities of respiratory function due to scoliosis, the risk of perioperative respiratory complications is increased. Further, airway obstruction secondary to kinking of the endotracheal tube in patients with scoliosis may occur.14 Clearing airway secretions is difficult and lung volumes are reduced in such patients.15 When a patient has a swallowing disorder leading to recurrent aspiration, aspiration of oral secretions should be presented. To prevent aspiration, premedication with H2 receptor antagonists and atropine is recommended.
Moreover, JBD may present autonomic nerve dysfunction, including abnormalities of thermal regulation, in addition to several metabolic disorders. It has been shown that the normal body temperature rhythm is disturbed in about half of patients with NCL.16 The persistent hypothermia observed in this patient may have been due to an abnormality of thermal regulation. Special attention to the prevention and treatment of hypothermia appears essential in a patient with JBD.
In summary, general anesthesia using thiamylal and sevoflurane provided satisfactory anesthetic and operative conditions in a patient with JBD. Intraoperative hypothermia required particular attention.
Revision received September 17, 2001. Accepted for publication March 26, 2001.
| References |
|---|
|
|
|---|
2 Rider JA, Rider DL. Batten disease: past, present, and future. Am J Med Genet 1988; Suppl 5: 216.
3 Oishi K, Ida H, Kurosawa K, Eto Y. Clinical and molecular analysis of Japanese patients with neuronal ceroid lipofuscinosis. Mol Genet Metab 1999; 66: 3448.[Medline]
4 Defalque RJ. Anesthesia for a patient with Kufs' disease. Anesthesiology 1990; 73: 10412.[Medline]
5 Azar I. The responses of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology 1984; 61: 17387.[Medline]
6 Eger EI II. New inhaled anesthetics. Anesthesiology 1994; 80: 90622.[Medline]
7
Kimura T, Watanabe S, Asakura N, Inomata S, Okada M, Taguchi M. Determination of end-tidal sevoflurane concentration for tracheal intubation and minimum alveolar anesthetic concentration in adults. Anesth Analg 1994; 79: 37881.
8 Stoelting RK. Antiepileptic drugs. In: Stoelting RK (Ed.). Pharmacology & Physiology in Anesthetic Practice. Philadelphia: JB Lippincott, 1987: 5219.
9 Stoelting RK. Barbiturates. In: Stoelting RK (Ed.). Pharmacology & Physiology in Anesthetic Practice. Philadelphia: JB Lippincott, 1987: 10217.
10 Nolan J, Chalkiadis GA, Low J, Olesch CA, Brown TCK. Anaesthesia and pain management in cerebral palsy. Anaesthesia 2000; 55: 3241.[Medline]
11
Adachi M, Ikemoto Y, Kubo K, Takuma C. Seizure-like movements during induction of anaesthesia with sevoflurane. Br J Anaesth 1992; 68: 2145.
12 Terasako K, Ishii S. Postoperative seizure-like activity following sevoflurane anesthesia. Acta Anesthesiol Scand 1996; 40: 9534.[Medline]
13 Poulton TJ, Ellingson RJ. Seizure associated with induction of anesthesia with isoflurane. Anesthesiology 1984; 61: 4716.[Medline]
14
Mesrobian RB, Epps JL. Midtracheal obstruction after Harrington rod placement in a patient with Marfan's syndrome. Anesth Analg 1986; 65: 4113.
15 Kafer ER. Respiratory and cardiovascular functions in scoliosis and the principles of anesthetic management. Anesthesiology 1980; 52: 33951.[Medline]
16 Heikkilä E, Hàtònen TH, Telakivi T, et al. Circadian rhythm studies in neuronal ceroid-lipofuscinosis (NCL). Am J Med Genet 1995; 57: 22934.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |